ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Osteoarthritis Cell Therapy Market Research Report 2026
Published Date: 2026-01-26
|
Report Code: QYRE-Auto-1M18708
Home | Market Reports | Health| Health Foundations & Medical Research
Global Osteoarthritis Cell Therapy Market Research Report 2024
BUY CHAPTERS

Global Osteoarthritis Cell Therapy Market Research Report 2026

Code: QYRE-Auto-1M18708
Report
2026-01-26
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Vericel
Medi post
Zimmer Biomet
Japan Tissue Engineering
Orthocell
Theracell Advanced Biotechnology
Nature Cell
Stempeutics
CellTex Therapeutics
UCI Health
Magellan
Cambium Bio
CO.DON GmbH
Regrow Biosciences
Xintela AB
Cells for Cells
AbelZeta Pharma

Osteoarthritis Cell Therapy Market Size

The global Osteoarthritis Cell Therapy market was valued at US$ 424 million in 2025 and is anticipated to reach US$ 2644 million by 2032, at a CAGR of 30.3% from 2026 to 2032.

Osteoarthritis Cell Therapy Market

Osteoarthritis Cell Therapy Market

Osteoarthritis Cell Therapy is an innovative treatment approach for osteoarthritis. It primarily involves the use of specific cells such as chondrocytes and mesenchymal stem cells. These cells are usually obtained from the patient's own joint cartilage, bone marrow, or adipose tissue, and then cultured, expanded, or induced to differentiate in vitro. Subsequently, they are implanted into the joint through intra - articular injection or tissue - engineered transplantation.
The North American market for Osteoarthritis Cell Therapy is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Osteoarthritis Cell Therapy is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Osteoarthritis Cell Therapy in Primary Osteoarthritis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Osteoarthritis Cell Therapy include Vericel, Medi-post, Zimmer Biomet, Japan Tissue Engineering, Orthocell, Cambium Bio, CO.DON GmbH, Regrow Biosciences, Theracell Advanced Biotechnology, Nature Cell, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Osteoarthritis Cell Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Osteoarthritis Cell Therapy. The Osteoarthritis Cell Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Osteoarthritis Cell Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Osteoarthritis Cell Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Osteoarthritis Cell Therapy Market Report

Report Metric Details
Report Name Osteoarthritis Cell Therapy Market
Accounted market size in 2025 US$ 424 million
Forecasted market size in 2032 US$ 2644 million
CAGR 30.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Chondrocytes
  • Mesenchymal Stem Cells
  • Others
Segment by Application
  • Primary Osteoarthritis
  • Secondary Osteoarthritis
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Vericel, Medi-post, Zimmer Biomet, Japan Tissue Engineering, Orthocell, Cambium Bio, CO.DON GmbH, Regrow Biosciences, Theracell Advanced Biotechnology, Nature Cell, Stempeutics, Xintela AB, Cells for Cells, CellTex Therapeutics, UCI Health, Magellan, AbelZeta Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Osteoarthritis Cell Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Osteoarthritis Cell Therapy Market growing?

Ans: The Osteoarthritis Cell Therapy Market witnessing a CAGR of 30.3% during the forecast period 2026-2032.

What is the Osteoarthritis Cell Therapy Market size in 2032?

Ans: The Osteoarthritis Cell Therapy Market size in 2032 will be US$ 2644 million.

Who are the main players in the Osteoarthritis Cell Therapy Market report?

Ans: The main players in the Osteoarthritis Cell Therapy Market are Vericel, Medi-post, Zimmer Biomet, Japan Tissue Engineering, Orthocell, Cambium Bio, CO.DON GmbH, Regrow Biosciences, Theracell Advanced Biotechnology, Nature Cell, Stempeutics, Xintela AB, Cells for Cells, CellTex Therapeutics, UCI Health, Magellan, AbelZeta Pharma

What are the Application segmentation covered in the Osteoarthritis Cell Therapy Market report?

Ans: The Applications covered in the Osteoarthritis Cell Therapy Market report are Primary Osteoarthritis, Secondary Osteoarthritis

What are the Type segmentation covered in the Osteoarthritis Cell Therapy Market report?

Ans: The Types covered in the Osteoarthritis Cell Therapy Market report are Chondrocytes, Mesenchymal Stem Cells, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Osteoarthritis Cell Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Chondrocytes
1.2.3 Mesenchymal Stem Cells
1.2.4 Others
1.3 Market by Application
1.3.1 Global Osteoarthritis Cell Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Primary Osteoarthritis
1.3.3 Secondary Osteoarthritis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Osteoarthritis Cell Therapy Market Perspective (2021–2032)
2.2 Global Osteoarthritis Cell Therapy Growth Trends by Region
2.2.1 Global Osteoarthritis Cell Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Osteoarthritis Cell Therapy Historic Market Size by Region (2021–2026)
2.2.3 Osteoarthritis Cell Therapy Forecasted Market Size by Region (2027–2032)
2.3 Osteoarthritis Cell Therapy Market Dynamics
2.3.1 Osteoarthritis Cell Therapy Industry Trends
2.3.2 Osteoarthritis Cell Therapy Market Drivers
2.3.3 Osteoarthritis Cell Therapy Market Challenges
2.3.4 Osteoarthritis Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Osteoarthritis Cell Therapy Players by Revenue
3.1.1 Global Top Osteoarthritis Cell Therapy Players by Revenue (2021–2026)
3.1.2 Global Osteoarthritis Cell Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Osteoarthritis Cell Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Osteoarthritis Cell Therapy Revenue
3.4 Global Osteoarthritis Cell Therapy Market Concentration Ratio
3.4.1 Global Osteoarthritis Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Osteoarthritis Cell Therapy Revenue in 2025
3.5 Global Key Players of Osteoarthritis Cell Therapy Head Offices and Areas Served
3.6 Global Key Players of Osteoarthritis Cell Therapy, Products and Applications
3.7 Global Key Players of Osteoarthritis Cell Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Osteoarthritis Cell Therapy Breakdown Data by Type
4.1 Global Osteoarthritis Cell Therapy Historic Market Size by Type (2021–2026)
4.2 Global Osteoarthritis Cell Therapy Forecasted Market Size by Type (2027–2032)
5 Osteoarthritis Cell Therapy Breakdown Data by Application
5.1 Global Osteoarthritis Cell Therapy Historic Market Size by Application (2021–2026)
5.2 Global Osteoarthritis Cell Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Osteoarthritis Cell Therapy Market Size (2021–2032)
6.2 North America Osteoarthritis Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Osteoarthritis Cell Therapy Market Size by Country (2021–2026)
6.4 North America Osteoarthritis Cell Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Osteoarthritis Cell Therapy Market Size (2021–2032)
7.2 Europe Osteoarthritis Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Osteoarthritis Cell Therapy Market Size by Country (2021–2026)
7.4 Europe Osteoarthritis Cell Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Osteoarthritis Cell Therapy Market Size (2021–2032)
8.2 Asia-Pacific Osteoarthritis Cell Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Osteoarthritis Cell Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Osteoarthritis Cell Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Osteoarthritis Cell Therapy Market Size (2021–2032)
9.2 Latin America Osteoarthritis Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Osteoarthritis Cell Therapy Market Size by Country (2021–2026)
9.4 Latin America Osteoarthritis Cell Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Osteoarthritis Cell Therapy Market Size (2021–2032)
10.2 Middle East & Africa Osteoarthritis Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Osteoarthritis Cell Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Osteoarthritis Cell Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Vericel
11.1.1 Vericel Company Details
11.1.2 Vericel Business Overview
11.1.3 Vericel Osteoarthritis Cell Therapy Introduction
11.1.4 Vericel Revenue in Osteoarthritis Cell Therapy Business (2021–2026)
11.1.5 Vericel Recent Development
11.2 Medi-post
11.2.1 Medi-post Company Details
11.2.2 Medi-post Business Overview
11.2.3 Medi-post Osteoarthritis Cell Therapy Introduction
11.2.4 Medi-post Revenue in Osteoarthritis Cell Therapy Business (2021–2026)
11.2.5 Medi-post Recent Development
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Details
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Osteoarthritis Cell Therapy Introduction
11.3.4 Zimmer Biomet Revenue in Osteoarthritis Cell Therapy Business (2021–2026)
11.3.5 Zimmer Biomet Recent Development
11.4 Japan Tissue Engineering
11.4.1 Japan Tissue Engineering Company Details
11.4.2 Japan Tissue Engineering Business Overview
11.4.3 Japan Tissue Engineering Osteoarthritis Cell Therapy Introduction
11.4.4 Japan Tissue Engineering Revenue in Osteoarthritis Cell Therapy Business (2021–2026)
11.4.5 Japan Tissue Engineering Recent Development
11.5 Orthocell
11.5.1 Orthocell Company Details
11.5.2 Orthocell Business Overview
11.5.3 Orthocell Osteoarthritis Cell Therapy Introduction
11.5.4 Orthocell Revenue in Osteoarthritis Cell Therapy Business (2021–2026)
11.5.5 Orthocell Recent Development
11.6 Cambium Bio
11.6.1 Cambium Bio Company Details
11.6.2 Cambium Bio Business Overview
11.6.3 Cambium Bio Osteoarthritis Cell Therapy Introduction
11.6.4 Cambium Bio Revenue in Osteoarthritis Cell Therapy Business (2021–2026)
11.6.5 Cambium Bio Recent Development
11.7 CO.DON GmbH
11.7.1 CO.DON GmbH Company Details
11.7.2 CO.DON GmbH Business Overview
11.7.3 CO.DON GmbH Osteoarthritis Cell Therapy Introduction
11.7.4 CO.DON GmbH Revenue in Osteoarthritis Cell Therapy Business (2021–2026)
11.7.5 CO.DON GmbH Recent Development
11.8 Regrow Biosciences
11.8.1 Regrow Biosciences Company Details
11.8.2 Regrow Biosciences Business Overview
11.8.3 Regrow Biosciences Osteoarthritis Cell Therapy Introduction
11.8.4 Regrow Biosciences Revenue in Osteoarthritis Cell Therapy Business (2021–2026)
11.8.5 Regrow Biosciences Recent Development
11.9 Theracell Advanced Biotechnology
11.9.1 Theracell Advanced Biotechnology Company Details
11.9.2 Theracell Advanced Biotechnology Business Overview
11.9.3 Theracell Advanced Biotechnology Osteoarthritis Cell Therapy Introduction
11.9.4 Theracell Advanced Biotechnology Revenue in Osteoarthritis Cell Therapy Business (2021–2026)
11.9.5 Theracell Advanced Biotechnology Recent Development
11.10 Nature Cell
11.10.1 Nature Cell Company Details
11.10.2 Nature Cell Business Overview
11.10.3 Nature Cell Osteoarthritis Cell Therapy Introduction
11.10.4 Nature Cell Revenue in Osteoarthritis Cell Therapy Business (2021–2026)
11.10.5 Nature Cell Recent Development
11.11 Stempeutics
11.11.1 Stempeutics Company Details
11.11.2 Stempeutics Business Overview
11.11.3 Stempeutics Osteoarthritis Cell Therapy Introduction
11.11.4 Stempeutics Revenue in Osteoarthritis Cell Therapy Business (2021–2026)
11.11.5 Stempeutics Recent Development
11.12 Xintela AB
11.12.1 Xintela AB Company Details
11.12.2 Xintela AB Business Overview
11.12.3 Xintela AB Osteoarthritis Cell Therapy Introduction
11.12.4 Xintela AB Revenue in Osteoarthritis Cell Therapy Business (2021–2026)
11.12.5 Xintela AB Recent Development
11.13 Cells for Cells
11.13.1 Cells for Cells Company Details
11.13.2 Cells for Cells Business Overview
11.13.3 Cells for Cells Osteoarthritis Cell Therapy Introduction
11.13.4 Cells for Cells Revenue in Osteoarthritis Cell Therapy Business (2021–2026)
11.13.5 Cells for Cells Recent Development
11.14 CellTex Therapeutics
11.14.1 CellTex Therapeutics Company Details
11.14.2 CellTex Therapeutics Business Overview
11.14.3 CellTex Therapeutics Osteoarthritis Cell Therapy Introduction
11.14.4 CellTex Therapeutics Revenue in Osteoarthritis Cell Therapy Business (2021–2026)
11.14.5 CellTex Therapeutics Recent Development
11.15 UCI Health
11.15.1 UCI Health Company Details
11.15.2 UCI Health Business Overview
11.15.3 UCI Health Osteoarthritis Cell Therapy Introduction
11.15.4 UCI Health Revenue in Osteoarthritis Cell Therapy Business (2021–2026)
11.15.5 UCI Health Recent Development
11.16 Magellan
11.16.1 Magellan Company Details
11.16.2 Magellan Business Overview
11.16.3 Magellan Osteoarthritis Cell Therapy Introduction
11.16.4 Magellan Revenue in Osteoarthritis Cell Therapy Business (2021–2026)
11.16.5 Magellan Recent Development
11.17 AbelZeta Pharma
11.17.1 AbelZeta Pharma Company Details
11.17.2 AbelZeta Pharma Business Overview
11.17.3 AbelZeta Pharma Osteoarthritis Cell Therapy Introduction
11.17.4 AbelZeta Pharma Revenue in Osteoarthritis Cell Therapy Business (2021–2026)
11.17.5 AbelZeta Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Vericel
Medi post
Zimmer Biomet
Japan Tissue Engineering
Orthocell
Theracell Advanced Biotechnology
Nature Cell
Stempeutics
CellTex Therapeutics
UCI Health
Magellan
Cambium Bio
CO.DON GmbH
Regrow Biosciences
Xintela AB
Cells for Cells
AbelZeta Pharma
List of Tables
 Table 1. Global Osteoarthritis Cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Chondrocytes
 Table 3. Key Players of Mesenchymal Stem Cells
 Table 4. Key Players of Others
 Table 5. Global Osteoarthritis Cell Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Osteoarthritis Cell Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Osteoarthritis Cell Therapy Market Size by Region (US$ Million), 2021–2026
 Table 8. Global Osteoarthritis Cell Therapy Market Share by Region (2021–2026)
 Table 9. Global Osteoarthritis Cell Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global Osteoarthritis Cell Therapy Market Share by Region (2027–2032)
 Table 11. Osteoarthritis Cell Therapy Market Trends
 Table 12. Osteoarthritis Cell Therapy Market Drivers
 Table 13. Osteoarthritis Cell Therapy Market Challenges
 Table 14. Osteoarthritis Cell Therapy Market Restraints
 Table 15. Global Osteoarthritis Cell Therapy Revenue by Players (US$ Million), 2021–2026
 Table 16. Global Osteoarthritis Cell Therapy Market Share by Players (2021–2026)
 Table 17. Global Top Osteoarthritis Cell Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Osteoarthritis Cell Therapy Revenue, 2025
 Table 18. Ranking of Global Top Osteoarthritis Cell Therapy Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by Osteoarthritis Cell Therapy Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of Osteoarthritis Cell Therapy, Headquarters and Area Served
 Table 21. Global Key Players of Osteoarthritis Cell Therapy, Products and Applications
 Table 22. Global Key Players of Osteoarthritis Cell Therapy, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global Osteoarthritis Cell Therapy Market Size by Type (US$ Million), 2021–2026
 Table 25. Global Osteoarthritis Cell Therapy Revenue Market Share by Type (2021–2026)
 Table 26. Global Osteoarthritis Cell Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global Osteoarthritis Cell Therapy Revenue Market Share by Type (2027–2032)
 Table 28. Global Osteoarthritis Cell Therapy Market Size by Application (US$ Million), 2021–2026
 Table 29. Global Osteoarthritis Cell Therapy Revenue Market Share by Application (2021–2026)
 Table 30. Global Osteoarthritis Cell Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global Osteoarthritis Cell Therapy Revenue Market Share by Application (2027–2032)
 Table 32. North America Osteoarthritis Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America Osteoarthritis Cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 34. North America Osteoarthritis Cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe Osteoarthritis Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe Osteoarthritis Cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe Osteoarthritis Cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific Osteoarthritis Cell Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific Osteoarthritis Cell Therapy Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific Osteoarthritis Cell Therapy Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America Osteoarthritis Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America Osteoarthritis Cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America Osteoarthritis Cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa Osteoarthritis Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa Osteoarthritis Cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa Osteoarthritis Cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 47. Vericel Company Details
 Table 48. Vericel Business Overview
 Table 49. Vericel Osteoarthritis Cell Therapy Product
 Table 50. Vericel Revenue in Osteoarthritis Cell Therapy Business (US$ Million), 2021–2026
 Table 51. Vericel Recent Development
 Table 52. Medi-post Company Details
 Table 53. Medi-post Business Overview
 Table 54. Medi-post Osteoarthritis Cell Therapy Product
 Table 55. Medi-post Revenue in Osteoarthritis Cell Therapy Business (US$ Million), 2021–2026
 Table 56. Medi-post Recent Development
 Table 57. Zimmer Biomet Company Details
 Table 58. Zimmer Biomet Business Overview
 Table 59. Zimmer Biomet Osteoarthritis Cell Therapy Product
 Table 60. Zimmer Biomet Revenue in Osteoarthritis Cell Therapy Business (US$ Million), 2021–2026
 Table 61. Zimmer Biomet Recent Development
 Table 62. Japan Tissue Engineering Company Details
 Table 63. Japan Tissue Engineering Business Overview
 Table 64. Japan Tissue Engineering Osteoarthritis Cell Therapy Product
 Table 65. Japan Tissue Engineering Revenue in Osteoarthritis Cell Therapy Business (US$ Million), 2021–2026
 Table 66. Japan Tissue Engineering Recent Development
 Table 67. Orthocell Company Details
 Table 68. Orthocell Business Overview
 Table 69. Orthocell Osteoarthritis Cell Therapy Product
 Table 70. Orthocell Revenue in Osteoarthritis Cell Therapy Business (US$ Million), 2021–2026
 Table 71. Orthocell Recent Development
 Table 72. Cambium Bio Company Details
 Table 73. Cambium Bio Business Overview
 Table 74. Cambium Bio Osteoarthritis Cell Therapy Product
 Table 75. Cambium Bio Revenue in Osteoarthritis Cell Therapy Business (US$ Million), 2021–2026
 Table 76. Cambium Bio Recent Development
 Table 77. CO.DON GmbH Company Details
 Table 78. CO.DON GmbH Business Overview
 Table 79. CO.DON GmbH Osteoarthritis Cell Therapy Product
 Table 80. CO.DON GmbH Revenue in Osteoarthritis Cell Therapy Business (US$ Million), 2021–2026
 Table 81. CO.DON GmbH Recent Development
 Table 82. Regrow Biosciences Company Details
 Table 83. Regrow Biosciences Business Overview
 Table 84. Regrow Biosciences Osteoarthritis Cell Therapy Product
 Table 85. Regrow Biosciences Revenue in Osteoarthritis Cell Therapy Business (US$ Million), 2021–2026
 Table 86. Regrow Biosciences Recent Development
 Table 87. Theracell Advanced Biotechnology Company Details
 Table 88. Theracell Advanced Biotechnology Business Overview
 Table 89. Theracell Advanced Biotechnology Osteoarthritis Cell Therapy Product
 Table 90. Theracell Advanced Biotechnology Revenue in Osteoarthritis Cell Therapy Business (US$ Million), 2021–2026
 Table 91. Theracell Advanced Biotechnology Recent Development
 Table 92. Nature Cell Company Details
 Table 93. Nature Cell Business Overview
 Table 94. Nature Cell Osteoarthritis Cell Therapy Product
 Table 95. Nature Cell Revenue in Osteoarthritis Cell Therapy Business (US$ Million), 2021–2026
 Table 96. Nature Cell Recent Development
 Table 97. Stempeutics Company Details
 Table 98. Stempeutics Business Overview
 Table 99. Stempeutics Osteoarthritis Cell Therapy Product
 Table 100. Stempeutics Revenue in Osteoarthritis Cell Therapy Business (US$ Million), 2021–2026
 Table 101. Stempeutics Recent Development
 Table 102. Xintela AB Company Details
 Table 103. Xintela AB Business Overview
 Table 104. Xintela AB Osteoarthritis Cell Therapy Product
 Table 105. Xintela AB Revenue in Osteoarthritis Cell Therapy Business (US$ Million), 2021–2026
 Table 106. Xintela AB Recent Development
 Table 107. Cells for Cells Company Details
 Table 108. Cells for Cells Business Overview
 Table 109. Cells for Cells Osteoarthritis Cell Therapy Product
 Table 110. Cells for Cells Revenue in Osteoarthritis Cell Therapy Business (US$ Million), 2021–2026
 Table 111. Cells for Cells Recent Development
 Table 112. CellTex Therapeutics Company Details
 Table 113. CellTex Therapeutics Business Overview
 Table 114. CellTex Therapeutics Osteoarthritis Cell Therapy Product
 Table 115. CellTex Therapeutics Revenue in Osteoarthritis Cell Therapy Business (US$ Million), 2021–2026
 Table 116. CellTex Therapeutics Recent Development
 Table 117. UCI Health Company Details
 Table 118. UCI Health Business Overview
 Table 119. UCI Health Osteoarthritis Cell Therapy Product
 Table 120. UCI Health Revenue in Osteoarthritis Cell Therapy Business (US$ Million), 2021–2026
 Table 121. UCI Health Recent Development
 Table 122. Magellan Company Details
 Table 123. Magellan Business Overview
 Table 124. Magellan Osteoarthritis Cell Therapy Product
 Table 125. Magellan Revenue in Osteoarthritis Cell Therapy Business (US$ Million), 2021–2026
 Table 126. Magellan Recent Development
 Table 127. AbelZeta Pharma Company Details
 Table 128. AbelZeta Pharma Business Overview
 Table 129. AbelZeta Pharma Osteoarthritis Cell Therapy Product
 Table 130. AbelZeta Pharma Revenue in Osteoarthritis Cell Therapy Business (US$ Million), 2021–2026
 Table 131. AbelZeta Pharma Recent Development
 Table 132. Research Programs/Design for This Report
 Table 133. Key Data Information from Secondary Sources
 Table 134. Key Data Information from Primary Sources
 Table 135. Authors List of This Report


List of Figures
 Figure 1. Osteoarthritis Cell Therapy Picture
 Figure 2. Global Osteoarthritis Cell Therapy Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Osteoarthritis Cell Therapy Market Share by Type: 2025 vs 2032
 Figure 4. Chondrocytes Features
 Figure 5. Mesenchymal Stem Cells Features
 Figure 6. Others Features
 Figure 7. Global Osteoarthritis Cell Therapy Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global Osteoarthritis Cell Therapy Market Share by Application: 2025 vs 2032
 Figure 9. Primary Osteoarthritis Case Studies
 Figure 10. Secondary Osteoarthritis Case Studies
 Figure 11. Osteoarthritis Cell Therapy Report Years Considered
 Figure 12. Global Osteoarthritis Cell Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 13. Global Osteoarthritis Cell Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Osteoarthritis Cell Therapy Market Share by Region: 2025 vs 2032
 Figure 15. Global Osteoarthritis Cell Therapy Market Share by Players in 2025
 Figure 16. Global Osteoarthritis Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by Osteoarthritis Cell Therapy Revenue in 2025
 Figure 18. North America Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 19. North America Osteoarthritis Cell Therapy Market Share by Country (2021–2032)
 Figure 20. United States Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Canada Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Osteoarthritis Cell Therapy Market Share by Country (2021–2032)
 Figure 24. Germany Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. France Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. U.K. Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Italy Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Russia Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Ireland Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Osteoarthritis Cell Therapy Market Share by Region (2021–2032)
 Figure 32. China Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Japan Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. South Korea Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Southeast Asia Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. India Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Australia & New Zealand Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Osteoarthritis Cell Therapy Market Share by Country (2021–2032)
 Figure 40. Mexico Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Brazil Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Osteoarthritis Cell Therapy Market Share by Country (2021–2032)
 Figure 44. Israel Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Saudi Arabia Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. UAE Osteoarthritis Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Vericel Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2021–2026)
 Figure 48. Medi-post Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2021–2026)
 Figure 49. Zimmer Biomet Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2021–2026)
 Figure 50. Japan Tissue Engineering Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2021–2026)
 Figure 51. Orthocell Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2021–2026)
 Figure 52. Cambium Bio Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2021–2026)
 Figure 53. CO.DON GmbH Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2021–2026)
 Figure 54. Regrow Biosciences Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2021–2026)
 Figure 55. Theracell Advanced Biotechnology Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2021–2026)
 Figure 56. Nature Cell Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2021–2026)
 Figure 57. Stempeutics Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2021–2026)
 Figure 58. Xintela AB Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2021–2026)
 Figure 59. Cells for Cells Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2021–2026)
 Figure 60. CellTex Therapeutics Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2021–2026)
 Figure 61. UCI Health Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2021–2026)
 Figure 62. Magellan Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2021–2026)
 Figure 63. AbelZeta Pharma Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2021–2026)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Osteoarthritis Chondrocyte Therapy Market Research Report 2024
Global Osteoarthritis Autologous Chondrocyte Therapy Market Research Report 2024
Global Stem Cell Therapy for Osteoarthritis Market Research Report 2024
Global Rheumatoid Arthritis Stem Cell Therapy Market Research Report 2024
Global Advanced Cell Therapies Market Research Report 2024
Global Musculoskeletal Disorder Stem Cell Therapy Market Insights Forecast to 2030
Global Stem Cell Therapy Market Insights Forecast to 2030
Global Osteoarthritis Therapeutics Market Research Report 2024
Global Cell Therapy Market Insights Forecast to 2030
Global Stem Cell Treatments Market Insights Forecast to 2030
Global Autologous Cell Therapy Products Market Research Report 2024
Global Cell Therapy Regenerative Medicine Market Research Report 2025
Global Mesenchymal Stem Cell Injection Market Research Report 2024
Global Cellular Therapy Products Market Research Report 2024
Global Cell Therapy and Tissue Engineering Market Insights Forecast to 2030
Global Animal Stem Cell Therapy Market Research Report 2025
Global Autologous Cell Therapy Market Insights Forecast to 2030
Global Mesenchymal Stem Cell Drugs Market Research Report 2024
Global Stem Cell Therapy for Pets Market Research Report 2024
Global Stem Cell Therapy for Infertility Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions